Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

394041424344454647

TOP NEWS: AstraZeneca swings to third-quarter profit and ups guidance

10th Nov 2022 10:48

(Alliance News) - AstraZeneca PLC on Thursday said it was continuing to see the benefit of sustained investment, as it raised its annual guidance on the back of strong results in the year to date. Read More

LONDON MARKET OPEN: Centrica helps FTSE 100 outperform ahead of US CPI

10th Nov 2022 08:53

(Alliance News) - Stocks in Europe struggled early on Thursday, though the FTSE 100 notched a minor gain, as investors held their breath ahead of all-important inflation data from the world's largest economy. Read More

LONDON BRIEFING: AstraZeneca and Haleon lift annual guidance

10th Nov 2022 07:58

(Alliance News) - Stocks in London are called lower on Thursday, with a stack of UK corporate updates keeping investors busy until the afternoon's eagerly-anticipated US inflation reading. Read More

AstraZeneca celebrates asthma treatment recommendation by US FDA

9th Nov 2022 09:53

(Alliance News) - AstraZeneca PLC on Wednesday said it is well-placed to transform current asthma emergency treatment approaches, after its inhaler was recommended by the US Food & Drug Administration. Read More

IN BRIEF: Beximco Pharmaceuticals revenue up thanks to domestic sales

8th Nov 2022 13:00

Beximco Pharmaceuticals Ltd - Dhaka-based generic pharmaceutical products and active pharmaceutical ingredients maker - In the financial year that ended June 30, books pretax profit of BDT6.69 billion, around GBP57.6 million, up 4.9% from BDT6.37 billion a year before. Annual revenue climbs 18% to BDT34.67 billion from BDT29.49 billion, with domestic sales rising by 21% and export sales by 14%. Declares BDT3.5 per share dividend. Read More

AstraZeneca notes positive phase III analysis for heart failure drug

7th Nov 2022 19:59

(Alliance News) - AstraZeneca PLC on Monday shared more positive data for Farxiga for use in the treatment of heart failure. Read More

LONDON MARKET OPEN: FTSE 100 boosted by miners as commodities rise

4th Nov 2022 09:01

(Alliance News) - Stocks were higher in London early Friday, as mining stocks lifted the FTSE 100, buoyed by rumours of an end to China's zero-tolerance Covid policies. Read More

TOP NEWS: AstraZeneca's Beyfortus wins EU approval for RSV in newborns

4th Nov 2022 08:08

(Alliance News) - AstraZeneca PLC on Friday said its respiratory syncytial virus treatment Beyfortus, or nirsevimab, which it develops with Sanofi SA, has received EU approval for prevention of the virus in newborns and infants. Read More

LONDON BRIEFING: Stocks called higher; US job growth expected to slow

4th Nov 2022 07:49

(Alliance News) - Stock prices in London were called higher on Friday in the wake of US Federal Reserve and Bank of England rate hikes, as markets now await a key US jobs report, expected to show a softening in the labour market. Read More

UK earnings, trading statements calendar - next 7 days

3rd Nov 2022 15:47

Read More

TOP NEWS: AstraZeneca's Vaxzevria wins full market authorisation in EU

1st Nov 2022 10:35

(Alliance News) - AstraZeneca PLC on Tuesday said its Covid vaccine Vaxzevria won full marketing authorisation in the EU. Read More

LONDON BRIEFING: FTSE 100 to open higher; BP swings to profit

1st Nov 2022 07:56

(Alliance News) - Stocks in London are set to open in the green on Tuesday, as the US Federal Reserve policy meeting gets underway. Read More

AstraZeneca to present new cardiovascular, renal drug data in US

31st Oct 2022 12:05

(Alliance News) - AstraZeneca PLC on Monday said it will present new data on cardiovascular and renal disease drugs in the US between Thursday and Monday next week. Read More

AstraZeneca's Ultomiris treatment gets good results from Phase 3 trial

27th Oct 2022 10:58

(Alliance News) - AstraZeneca PLC on Thursday said phase 3 trial results for its Ultomiris treatment showed a "significant" reduction in the risk of relapse in adults with neuromyelitis optica spectrum disorder. Read More

Study confirms AstraZeneca jab's higher risk of very rare clot

27th Oct 2022 06:11

(Alliance News) - AstraZeneca PLC's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer Inc jab, a large international study said Thursday. Read More

TOP NEWS: AstraZeneca hails survival rates of breast cancer drugs

26th Oct 2022 09:36

(Alliance News) - AstraZeneca PLC on Wednesday said its breast cancer drugs capivasertib and camizestrant significantly improved progression-free survival in a phase 3 and 2 trial respectively. Read More

LONDON MARKET OPEN: Sterling climbs above USD1.15, euro above parity

26th Oct 2022 08:49

(Alliance News) - London's FTSE 100 index moved lower at the open on Wednesday, as the pound continued to climb higher on the potential for the stability that a Rishi Sunak premiership could bring to Westminster. Read More

TOP NEWS: AstraZeneca's Fasenra fails to meet trial's primary endpoint

25th Oct 2022 08:24

(Alliance News) - AstraZeneca PLC on Tuesday said that its Fasenra treatment failed to meet one of its two primary endpoints in its Messina Phase 3 trial in eosinophilic esophagitis. Read More

AstraZeneca treatment gets FDA approval for US liver cancer patients

24th Oct 2022 08:23

(Alliance News) - AstraZeneca PLC on Monday said one of its treatments has been approved in the US for treating adults with unresectable liver cancer. Read More

TOP NEWS: AstraZeneca says Evusheld shows promise on Covid variants

20th Oct 2022 09:06

(Alliance News) - AstraZeneca PLC on Thursday said that new analyses from a phase 3 treatment trial show the potential of its Covid drug Evusheld to reduce severity and mortality. Read More

394041424344454647
FTSE 100 Latest
Value10,524.97
Change58.71